More
than 10 million people suffer from cardiovascular diseases,
and diseased blood vessels need to be treated with vascular patches.
For a vascular patch, good affinity for endothelial progenitor cells
is a key factor in promoting the formation of endothelial tissueendothelialization.
To construct such a vascular patch with good cell affnity, in this
work, we first synthesized a reactive zwitterionic organophosphate
containing a phosphorylcholine headgroup: 6-(acryloyloxy)hexyl-2-(N-isopropyl-N,N-dimethylammonio)ethyl
phosphate (AHEP). We then grafted AHEP onto a polylactic acid (PLA)-coated
decellularized scaffold to obtain a vascular patch. Its hydrophilicity
and biocompatibility were investigated. Its in vivo performance was
also examined in a pig model with B-ultrasonography, Doppler spectra,
and computed tomography angiography. The vascular patch demonstrated
a nonhemolytic property, noncytotoxicity, long in vitro coagulation
times, the strong ability to resist platelet adhesion, and a good
affinity for endothelial progenitor cells. The vascular patch was
able to maintain the long-term patency (5 months) of surgical arteries.
Hence, the zwitterionic polymer-grafted PLA vascular patch may be
a promising candidate for vascular tissue engineering.